Vascular impairment in patients with primary biliary cirrhosis.

B. Marasini; C. Pipia; G. DeValle; A. Crosignani; L. Petroni; M. Cugno; S. Zeni; S. Bruno; C. Bassani

Vascular impairment in patients with primary biliary cirrhosis.

B. Marasini, C. Pipia, G. DeValle, A. Crosignani, L. Petroni, M. Cugno, S. Zeni, S. Bruno, C. Bassani

Research output: Contribution to journal › Article › peer-review

Abstract

Experimental and clinical observation suggest that patients with primary biliary cirrhosis (PBC) have endothelial dysfunction. Postischemic digital blood flow, nailfold capillaroscopy, von Willebrand factor (vWf) and tissue-type plasminogen activator (t-PA) plasma levels were examined in 59 PBC patients. Forty-six subjects (15 with liver diseases other than PBC, 11 hypercholesterolemics, 20 healthy subjects) served as controls. PBC versus healthy controls (209.8 +/- 1.4% and 16.54 +/- 1.44 ng/ml vs. 120.2 +/- 1.4% and 9.91 +/- 1.49 ng/ml; p

Original language	English
Pages (from-to)	75-79
Number of pages	5
Journal	International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation
Volume	15
Issue number	2
Publication status	Published - Mar 1995

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology

Fingerprint Dive into the research topics of 'Vascular impairment in patients with primary biliary cirrhosis.'. Together they form a unique fingerprint.

Cite this

Vascular impairment in patients with primary biliary cirrhosis. / Marasini, B.; Pipia, C.; DeValle, G.; Crosignani, A.; Petroni, L.; Cugno, M.; Zeni, S.; Bruno, S.; Bassani, C.

In: International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation, Vol. 15, No. 2, 03.1995, p. 75-79.

Research output: Contribution to journal › Article › peer-review

@article{dea0950cd97f4f8f803eadb0b13c0477,

title = "Vascular impairment in patients with primary biliary cirrhosis.",

abstract = "Experimental and clinical observation suggest that patients with primary biliary cirrhosis (PBC) have endothelial dysfunction. Postischemic digital blood flow, nailfold capillaroscopy, von Willebrand factor (vWf) and tissue-type plasminogen activator (t-PA) plasma levels were examined in 59 PBC patients. Forty-six subjects (15 with liver diseases other than PBC, 11 hypercholesterolemics, 20 healthy subjects) served as controls. PBC versus healthy controls (209.8 +/- 1.4% and 16.54 +/- 1.44 ng/ml vs. 120.2 +/- 1.4% and 9.91 +/- 1.49 ng/ml; p",

author = "B. Marasini and C. Pipia and G. DeValle and A. Crosignani and L. Petroni and M. Cugno and S. Zeni and S. Bruno and C. Bassani",

year = "1995",

month = mar,

language = "English",

volume = "15",

pages = "75--79",

journal = "International Journal of Microcirculation-Clinical and Experimental",

issn = "0167-6865",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Vascular impairment in patients with primary biliary cirrhosis.

AU - Marasini, B.

AU - Pipia, C.

AU - DeValle, G.

AU - Crosignani, A.

AU - Petroni, L.

AU - Cugno, M.

AU - Zeni, S.

AU - Bruno, S.

AU - Bassani, C.

PY - 1995/3

Y1 - 1995/3

N2 - Experimental and clinical observation suggest that patients with primary biliary cirrhosis (PBC) have endothelial dysfunction. Postischemic digital blood flow, nailfold capillaroscopy, von Willebrand factor (vWf) and tissue-type plasminogen activator (t-PA) plasma levels were examined in 59 PBC patients. Forty-six subjects (15 with liver diseases other than PBC, 11 hypercholesterolemics, 20 healthy subjects) served as controls. PBC versus healthy controls (209.8 +/- 1.4% and 16.54 +/- 1.44 ng/ml vs. 120.2 +/- 1.4% and 9.91 +/- 1.49 ng/ml; p

AB - Experimental and clinical observation suggest that patients with primary biliary cirrhosis (PBC) have endothelial dysfunction. Postischemic digital blood flow, nailfold capillaroscopy, von Willebrand factor (vWf) and tissue-type plasminogen activator (t-PA) plasma levels were examined in 59 PBC patients. Forty-six subjects (15 with liver diseases other than PBC, 11 hypercholesterolemics, 20 healthy subjects) served as controls. PBC versus healthy controls (209.8 +/- 1.4% and 16.54 +/- 1.44 ng/ml vs. 120.2 +/- 1.4% and 9.91 +/- 1.49 ng/ml; p

UR - http://www.scopus.com/inward/record.url?scp=0029258807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029258807&partnerID=8YFLogxK

M3 - Article

C2 - 8655255

AN - SCOPUS:0029258807

VL - 15

SP - 75

EP - 79

JO - International Journal of Microcirculation-Clinical and Experimental

JF - International Journal of Microcirculation-Clinical and Experimental

SN - 0167-6865

IS - 2

ER -